MedTrace Logo

Screening Patients With Diabetes Mellitus for the Presence of Skin Disorder of Scleredema

NCT04335396 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-04-08

No results posted yet for this study

Summary

Scleredema is a scleroderma-like skin disorder appearing in 2.5-14% among patients with type 1 or 2 diabetes mellitus. This is a single centre study to screen consecutive patients with diabetes mellitus for the presence of scleredema,and to compare the clinical-laboratory data of patients with and without scleredema. Metabolic and vascular complications of these patients will be focused on.

Conditions

  • Diabetes Mellitus
  • Diabetes Complications
  • Scleroderma-Like Changes
  • Scleredema Adultorum

Sponsors & Collaborators

  • University of Pecs

    lead OTHER

Principal Investigators

  • Cecilia Varju, MD, PhD · Dept. Rheumatology and Immunology, University of Pécs, Hungary

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-28
Primary Completion
2020-05-30
Completion
2023-05-28

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04335396 on ClinicalTrials.gov